We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Protein Analysis Reveals Menopause-Associated Signals of Brain Aging

By LabMedica International staff writers
Posted on 04 Nov 2026

Menopause affects women across midlife and is often accompanied by endocrine changes, hot flashes, brain fog and sleep disturbances. More...

Women spend roughly one third of their lives after the menopause transition, yet links between this transition and later-life brain health remain incompletely understood. Blood-based biomarkers may help clarify biological changes that emerge before dementia is clinically apparent. 

Researchers at UC Santa Barbara, UC San Francisco, and collaborating international institutions identified a molecular signature involving 16 proteins associated with brain aging and dementia risk. Using advanced proteomic technologies, the team analyzed thousands of proteins in cohorts of pre-, peri-, and postmenopausal women from the Jacobs Lab’s Healthy Aging Study, which was established to examine brain and cognitive function in women and men during midlife.

The protein changes involved inflammatory and neuronal processes, as well as pathways associated with Alzheimer’s disease. These shifts were more closely related to menopause stage than to chronological age, suggesting that menopause itself, rather than aging alone, was associated with the observed molecular changes. The findings were confirmed in a separate dataset of more than 2,800 women from the UK Biobank, which also showed menopause-related molecular signatures linked to accelerated aging across multiple organ systems.

The researchers then examined how these molecular changes related to brain health using data from four independent cohorts totaling nearly 12,000 older women. Women with higher levels of these risk-associated proteins were more likely to have poorer cognitive outcomes. In the largest cohort, the protein signature was also associated with a modestly increased risk of developing Alzheimer’s dementia over the following 16 years.

The findings were published in Nature Medicine. Collaborating institutions included UC Santa Barbara, UC San Francisco, Stanford University, the University of Toronto and Sunnybrook Research Institute. The team’s goal is to develop a blood test that could act as an early-warning sign of dementia risk, while the authors note that longitudinal studies following the same women through menopause will be essential to understand how hormones, proteins, symptoms and brain health change together over time.

“Menopause is not an isolated reproductive event. It is a whole-body biological transition. Now we can begin to see a molecular fingerprint of that transition in the blood and ask how it relates to brain health decades later,” said Emily Jacobs, a professor of psychological and brain sciences at UCSB.

Related Links
UC Santa Barbara
UC San Francisco 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A blood test measuring circulating tumor DNA may help identify men with hormone-resistant oligoprogressive prostate cancer most likely to benefit from stereotactic body radiotherapy (Image Credit: Adobe Stock)

Blood Test Identifies Candidates for Targeted Radiotherapy in Advanced Prostate Cancer

Advanced prostate cancer can progress despite hormone-based treatment, with imaging sometimes revealing only limited areas of active disease. For men with hormone-resistant oligoprogressive prostate cancer,... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.